Investigation of the Intraoperative and Postoperative Effects of Warming Patients in Laparoscopic Cholecystectomy

Effects of Patient Warming With Electric Blanket on Intraoperative Hemodynamics; Postoperative Nausea, Vomiting, Chills, Agitation and Pain in Laparoscopic Cholecystectomy Operation

In our study, the investigators will investigate the effects of electric blanket heating on intraoperative hemodynamics, postoperative nausea, vomiting, shivering, agitation and pain in patients undergoing laparoscopic cholecystectomy under general anesthesia.

Study Overview

Detailed Description

Group 1: Patients warmed with electric blankets

  • Patients will be provided with electric blankets from the beginning to the end of the operation (approximately 1 hour)
  • all patients will receive standard general anesthesia
  • all patients will undergo electrocardiogram, peripheral oxygen saturation by pulse oximetry, non-invasive blood pressure monitoring by automatic pneumatic manometer.
  • each patient will undergo tympanic temperature measurement immediately before induction of general anesthesia, 20 minutes after induction of anesthesia, immediately after extubation and during exit from the postanesthesia recovery unit.
  • mean arterial pressure, intraoperative opioid consumption, nausea-vomiting, agitation, tremor and pain assessment will be performed on each patient immediately before induction of general anesthesia, 20 minutes after induction of anesthesia, immediately after extubation and during discharge from the postanesthesia recovery unit.
  • the same electric blanket was used for this group of patients
  • each time the electric blankets were set to 38 degrees and the blankets were preheated to 38 degrees approximately 30 minutes before the patients were placed on the operating table.
  • heat measurements will be made with the same tympanic heat meter device
  • heat measurements will be made by a blind anesthesiologist with at least 5 years of experience
  • Postoperative evaluations of the patients will be performed face to face.
  • patients will be warmed only during the time they are on the operating table
  • This study was followed up in the operating room and post-anesthesia recovery unit in the operating room.

Group 2: Control group (patients without warming): no electric blanket will be used, and no heating will be applied to this group of patients.

  • all patients will receive standard general anesthesia.
  • all patients will undergo electrocardiogram, peripheral oxygen saturation by pulse oximetry, non-invasive blood pressure monitoring by automatic pneumatic manometer.
  • each patient will undergo tympanic temperature measurement immediately before induction of general anesthesia, 20 minutes after induction of anesthesia, immediately after extubation and during exit from the postanesthesia recovery unit.
  • mean arterial pressure, intraoperative opioid consumption, nausea-vomiting, agitation, tremor and pain assessment will be performed on each patient immediately before induction of general anesthesia, 20 minutes after induction of anesthesia, immediately after extubation and during discharge from the postanesthesia recovery unit.
  • temperature measurements will be performed with the same tympanic thermometer device
  • heat measurements will be made by a blind anesthesiologist with at least 5 years of experience
  • Postoperative evaluations of the patients will be performed face to face.
  • This study was followed up in the operating room and post-anesthesia recovery unit in the operating room.

Statistical methods / analysis: G-Power version 3.1.9.4 (University Kiel, Germany) was used to calculate the sample size. Two-tailed alpha error was 0.05, power as 0.80 and effect size as 0.5, and according to a previous study (Comparison of different end-tidal carbon dioxide levels in preventing postoperative nausea and vomiting in gynaecological patients undergoing laparoscopic surgery. Doi: 10.1080/01443615.2020.1789961.) allocation ratio was accepted as N2/N1:1. The minimum number of patients to be included in the study was calculated as 128.

Study Type

Interventional

Enrollment (Actual)

128

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Diyarbakır, Turkey, 21070
        • Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Laparoscopic cholecystectomy operation will be
  • To be between 18-65 years old.
  • Being American Society of Anesthesiologists (ASA) Classification I-II.

Exclusion Criteria:

  • Preoperative body temperature >37.5°C or <36°C.
  • Impaired temperature regulation such as systemic infection, mental retardation, isolated head trauma or brain injury.
  • Receiving a medication that affects thermoregulation.
  • Being American Society of Anesthesiologists (ASA) Classification >III.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Group 1: Patients warmed with electric blankets
  • Patients will be provided with electric blankets from the beginning to the end of the operation (approximately 1 hour)
  • all patients will receive standard general anesthesia
  • each patient will undergo tympanic temperature measurement immediately before induction of general anesthesia, 20 minutes after induction of anesthesia, immediately after extubation and during exit from the postanesthesia recovery unit.
  • the same electric blanket was used for this group of patients
  • each time the electric blankets were set to 38 degrees and the blankets were preheated to 38 degrees approximately 30 minutes before the patients were placed on the operating table.
  • heat measurements will be made with the same tympanic heat meter device
warmed with electric blankets
Other: Group 2: Control group (patients without warming)
  • no electric blanket will be used, and no heating will be applied to this group of patients.
  • all patients will receive standard general anesthesia
  • all patients will undergo electrocardiogram, peripheral oxygen saturation by pulse oximetry, non-invasive blood pressure monitoring by automatic pneumatic manometer
  • mean arterial pressure, intraoperative opioid consumption, nausea-vomiting, agitation, tremor and pain assessment will be performed on each patient immediately before induction of general anesthesia, 20 minutes after induction of anesthesia, immediately after extubation and during discharge from the postanesthesia recovery unit.
  • temperature measurements will be performed with the same tympanic thermometer device
patients without warming: no electric blanket will be used, and no heating will be applied to this group of patients.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Agitation assessment
Time Frame: Will be assessed from immediately after extubation until transfer from the recovery room to the ward.
Agitation assessment with Richmond Agitation Sedation Scale (RASS). The Richmond Agitation Sedation Scale (RASS) is a 10-point scale ranging from -5 to +4.Levels -1 to -5 denote 5 levels of sedation, starting with "awakens to voice" and ending with "unarousable." Levels +1 to +4 describe increasing levels of agitation. The lowest level of agitation starts with apprehension and anxiety, and peaks at combative and violent. RASS level 0 is "alert and calm.
Will be assessed from immediately after extubation until transfer from the recovery room to the ward.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain assessment
Time Frame: Within 30 minutes from the time the patient was extubated to the time of extubation from the postoperative recovery unit to the ward.
The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain."
Within 30 minutes from the time the patient was extubated to the time of extubation from the postoperative recovery unit to the ward.
post-operative tremor
Time Frame: Within 30 minutes from the time the patient was extubated to the time of extubation from the postoperative recovery unit to the ward.

The evaluation will be made according to this rating:

Grade 1: no tremor Grade 2: mild tremor with mild facial and cervical muscle contraction Grade 3: moderate tremor with obvious tremor of the head and neck, shoulders and/or extremities Grade 4: severe tremor consisting of an obvious tremor all over the body

Within 30 minutes from the time the patient was extubated to the time of extubation from the postoperative recovery unit to the ward.
Amount of fentanyl consumed intraoperatively
Time Frame: during surgery]
micrograms of fentanyl consumed
during surgery]
Average blood pressure
Time Frame: Assessments will be performed at 0 minutes immediately before induction of anesthesia, 20 minutes after induction, immediately after extubation and 20 minutes in the recovery unit after anesthesia.
Blood pressure will be measured with a non-invasive automatic pneumatic cuff in the operating theatre.
Assessments will be performed at 0 minutes immediately before induction of anesthesia, 20 minutes after induction, immediately after extubation and 20 minutes in the recovery unit after anesthesia.
Heart rate
Time Frame: Assessments will be performed at 0 minutes immediately before induction of anesthesia, 20 minutes after induction, immediately after extubation and 20 minutes in the recovery unit after anesthesia.
the measurement will be obtained by electrocardiographic monitoring
Assessments will be performed at 0 minutes immediately before induction of anesthesia, 20 minutes after induction, immediately after extubation and 20 minutes in the recovery unit after anesthesia.
nausea-vomiting
Time Frame: The evaluation will be performed at postoperative 0th hour, 2nd hour, 6th hour and 24th hour.

-Postoperative nausea and vomiting will be assessed using a 100 mm VAS:

1- severe nausea (VAS>70 mm), 2- moderate nausea (50<VAS<70 mm), 3- mild nausea (VAS <50 mm).

The evaluation will be performed at postoperative 0th hour, 2nd hour, 6th hour and 24th hour.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Cem K. Kaçar, Assoc.Prof, Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 3, 2023

Primary Completion (Actual)

August 19, 2024

Study Completion (Actual)

August 20, 2024

Study Registration Dates

First Submitted

August 15, 2023

First Submitted That Met QC Criteria

August 28, 2023

First Posted (Actual)

September 5, 2023

Study Record Updates

Last Update Posted (Actual)

August 21, 2024

Last Update Submitted That Met QC Criteria

August 20, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 11.25.2022/235

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Laparoscopic Cholecystectomy

Clinical Trials on warmed with electric blankets

Subscribe